New Research Collaboration Between BioXcel Therapeutics and Nektar to Evaluate BXCL701 in Combination with NKTR-214 in Multiple Oncology Indications Nov 13, 2017
BioXcel Therapeutics to Present Data on [BXCL701] at the 24th Annual Prostate Cancer Foundation Scientific Retreat Oct 5, 2017
InveniAI Is Launched with Industry-leading Artificial Intelligence (AI) Powered R&D Engine for Biotech and Pharma Partners May 16, 2017
BioXcel Therapeutics, Inc. (BTI) Is Launched with Phase 2-ready Programs Addressing Unmet Needs in Immuno-oncology and Neuroscience May 10, 2017
BioXcel Presents Promising Data Demonstrating BXCL701 / Anti-PD1 Combination Increases Anti-Tumor Cytokines and Tumor Growth Inhibition at 2017 AACR Annual Meeting Apr 3, 2017
BioXcel and Centrexion Therapeutics Further Advance Big Data Innovation Lab Collaboration in Chronic Pain Oct 19, 2016
